Skip to main content
Clinical Trials/NL-OMON37773
NL-OMON37773
Completed
Not Applicable

In vivo assessment of hypoxia in gastro-intestinal cancer using 18F-HX4-PET: an optimization and reproducibility study - Reproducibility of hypoxia measurment in GI cancer.

Academisch Medisch Centrum0 sites60 target enrollmentTBD
Conditionscancer10017990

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cancer
Sponsor
Academisch Medisch Centrum
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients with biopsy proven invasive carcinoma of the esophagus, pancreas or rectum. In pancreatic cancer cytological proof or a high suspicion on CT imaging is allowed, too.
  • \- Any tumor with a size \* 1cm
  • \- WHO\-performance score 0\-2
  • \- Written informed consent

Exclusion Criteria

  • \- Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol.
  • \- Surgery, radiation and/or chemotherapy foreseen within the timeframe needed for two PET scans.

Outcomes

Primary Outcomes

Not specified

Similar Trials